Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

• Noboru Shibasaki,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Toshinari Yamasaki,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Toru Kanno,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Ryuichiro Arakaki,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Hiromasa Sakamoto,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Noriaki Utsunomiya,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Takahiro Inoue,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Tatsuaki Tsuruyama,

  Affiliation Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Eijiro Nakamura,

  Affiliation Laboratory for Malignancy Control Research, Medical Innovation Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Osamu Ogawa,

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯
• Tomomi Kamba

  * E-mail: kamba@kuhp.kyoto-u.ac.jp

  Affiliation Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  ⨯